Literature DB >> 24836890

Dynamic interactions between cancer cells and the embryonic microenvironment regulate cell invasion and reveal EphB6 as a metastasis suppressor.

Caleb M Bailey1, Paul M Kulesa2.   

Abstract

UNLABELLED: Metastatic dissemination drives the high mortality associated with melanoma. However, difficulties in visualizing in vivo cell dynamics during metastatic invasion have limited our understanding of these cell behaviors. Recent evidence has revealed that melanoma cells exploit portions of their ancestral embryonic neural crest emigration program to facilitate invasion. What remains to be determined is how embryonic microenvironmental signals influence invasive melanoma cell behavior, and whether these signals are relevant to human disease. To address these questions, we interrogated the role of the neural crest microenvironment in dictating the spatiotemporal pattern of melanoma cell invasion in the chick embryo using 2-photon time-lapse microscopy. Results reveal that both permissive and inhibitory neural crest microenvironmental signals regulate the timing and direction of melanoma invasion to coincide with the neural crest migration pattern. These cues include bidirectional signaling mediated through the ephrin family of receptor tyrosine kinases. We demonstrate that EphB6 reexpression forces metastatic melanoma cells to deviate from the canonical migration pattern observed in the chick embryo transplant model. Furthermore, EphB6-expressing melanoma cells display significantly reduced metastatic potential in a chorioallantoic membrane (CAM) metastasis assay. These data on melanoma invasion in the embryonic neural crest and CAM microenvironments identify EphB6 as a metastasis suppressor in melanoma, likely acting at the stage of intravasation. IMPLICATIONS: This article links cellular metastasis to behaviors observed in the ancestrally related embryonic neural crest and demonstrates the powerful influence of the embryonic microenvironment in regulating cell migratory behavior. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24836890      PMCID: PMC4498260          DOI: 10.1158/1541-7786.MCR-13-0673

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  32 in total

Review 1.  Comparative analysis of neural crest cell death, migration, and function during vertebrate embryogenesis.

Authors:  Paul Kulesa; Debra L Ellies; Paul A Trainor
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

2.  Transcriptional silencing of EphB6 receptor tyrosine kinase in invasive breast carcinoma cells and detection of methylated promoter by methylation specific PCR.

Authors:  Brian P Fox; Raj P Kandpal
Journal:  Biochem Biophys Res Commun       Date:  2005-12-09       Impact factor: 3.575

Review 3.  Putative dual role of ephrin-Eph receptor interactions in inflammation.

Authors:  Andrei I Ivanov; Andrej A Romanovsky
Journal:  IUBMB Life       Date:  2006-07       Impact factor: 3.885

4.  The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells.

Authors:  A Smith; V Robinson; K Patel; D G Wilkinson
Journal:  Curr Biol       Date:  1997-08-01       Impact factor: 10.834

5.  Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration.

Authors:  C E Krull; R Lansford; N W Gale; A Collazo; C Marcelle; G D Yancopoulos; S E Fraser; M Bronner-Fraser
Journal:  Curr Biol       Date:  1997-08-01       Impact factor: 10.834

6.  The melanocyte differentiation program predisposes to metastasis after neoplastic transformation.

Authors:  Piyush B Gupta; Charlotte Kuperwasser; Jean-Philippe Brunet; Sridhar Ramaswamy; Wen-Lin Kuo; Joe W Gray; Stephen P Naber; Robert A Weinberg
Journal:  Nat Genet       Date:  2005-09-04       Impact factor: 38.330

7.  Biphasic functions of the kinase-defective Ephb6 receptor in cell adhesion and migration.

Authors:  Hiroshi Matsuoka; Hiroya Obama; Meghan L Kelly; Toshimitsu Matsui; Masaru Nakamoto
Journal:  J Biol Chem       Date:  2005-06-13       Impact factor: 5.157

8.  Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment.

Authors:  Paul M Kulesa; Jennifer C Kasemeier-Kulesa; Jessica M Teddy; Naira V Margaryan; Elisabeth A Seftor; Richard E B Seftor; Mary J C Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

9.  Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.

Authors:  J Kim; W Yu; K Kovalski; L Ossowski
Journal:  Cell       Date:  1998-08-07       Impact factor: 41.582

10.  Loss of EphB6 expression in metastatic melanoma.

Authors:  Christian Hafner; Frauke Bataille; Stefanie Meyer; Bernd Becker; Alexander Roesch; Michael Landthaler; Thomas Vogt
Journal:  Int J Oncol       Date:  2003-12       Impact factor: 5.650

View more
  11 in total

Review 1.  Neural crest and cancer: Divergent travelers on similar paths.

Authors:  Kristin L Gallik; Randall W Treffy; Lynne M Nacke; Kamil Ahsan; Manuel Rocha; Abigail Green-Saxena; Ankur Saxena
Journal:  Mech Dev       Date:  2017-09-06       Impact factor: 1.882

Review 2.  Neural crest migration: trailblazing ahead.

Authors:  Paul M Kulesa; Rebecca McLennan
Journal:  F1000Prime Rep       Date:  2015-01-05

3.  Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment.

Authors:  James M Paul; Behzad Toosi; Frederick S Vizeacoumar; Kalpana Kalyanasundaram Bhanumathy; Yue Li; Courtney Gerger; Amr El Zawily; Tanya Freywald; Deborah H Anderson; Darrell Mousseau; Rani Kanthan; Zhaolei Zhang; Franco J Vizeacoumar; Andrew Freywald
Journal:  Oncotarget       Date:  2016-08-02

4.  Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.

Authors:  Silvia Mateo-Lozano; Sarah Bazzocco; Paulo Rodrigues; Rocco Mazzolini; Elena Andretta; Higinio Dopeso; Yolanda Fernández; Edgar Del Llano; Josipa Bilic; Lucía Suárez-López; Irati Macaya; Fernando Cartón-García; Rocio Nieto; Lizbeth M Jimenez-Flores; Priscila Guimarães de Marcondes; Yaiza Nuñez; Elsa Afonso; Karina Cacci; Javier Hernández-Losa; Stefania Landolfi; Ibane Abasolo; Santiago Ramón Y Cajal; John M Mariadason; Simo Schwartz; Toshimitsu Matsui; Diego Arango
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

5.  Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment.

Authors:  Shufeng Zhou; Mohamed Abdouh; Vincenzo Arena; Manuel Arena; Goffredo Orazio Arena
Journal:  PLoS One       Date:  2017-01-09       Impact factor: 3.240

6.  NGF reprograms metastatic melanoma to a bipotent glial-melanocyte neural crest-like precursor.

Authors:  Jennifer C Kasemeier-Kulesa; Morgan H Romine; Jason A Morrison; Caleb M Bailey; Danny R Welch; Paul M Kulesa
Journal:  Biol Open       Date:  2018-01-11       Impact factor: 2.422

7.  EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.

Authors:  Behzad M Toosi; Amr El Zawily; Luke Truitt; Matthew Shannon; Odette Allonby; Mohan Babu; John DeCoteau; Darrell Mousseau; Mohsin Ali; Tanya Freywald; Amanda Gall; Frederick S Vizeacoumar; Morgan W Kirzinger; C Ronald Geyer; Deborah H Anderson; TaeHyung Kim; Alana L Welm; Peter Siegel; Franco J Vizeacoumar; Anthony Kusalik; Andrew Freywald
Journal:  Oncogene       Date:  2018-04-27       Impact factor: 9.867

8.  DAN (NBL1) promotes collective neural crest migration by restraining uncontrolled invasion.

Authors:  Rebecca McLennan; Caleb M Bailey; Linus J Schumacher; Jessica M Teddy; Jason A Morrison; Jennifer C Kasemeier-Kulesa; Lauren A Wolfe; Madeline M Gogol; Ruth E Baker; Philip K Maini; Paul M Kulesa
Journal:  J Cell Biol       Date:  2017-08-15       Impact factor: 10.539

Review 9.  Neuroblastoma Origin and Therapeutic Targets for Immunotherapy.

Authors:  Irina V Kholodenko; Daniel V Kalinovsky; Igor I Doronin; Sergey M Deyev; Roman V Kholodenko
Journal:  J Immunol Res       Date:  2018-07-11       Impact factor: 4.818

10.  Structure of the EphB6 receptor ectodomain.

Authors:  Emilia O Mason; Yehuda Goldgur; Dorothea Robev; Andrew Freywald; Dimitar B Nikolov; Juha P Himanen
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.